CompletedPhase 3NCT00931632
Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants
Studying Bronchopulmonary dysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mallinckrodt
- Principal Investigator
- James Baldassarre, MD, MDMallinckrodt
- Intervention
- Inhaled Nitric Oxide(drug)
- Enrollment
- 451 enrolled
- Eligibility
- All sexes
- Timeline
- 2009 – 2014
Study locations (30)
- Phoenix Children's Hospital, Phoenix, Arizona, United States
- St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
- Loma Linda University School of Medicine, Loma Linda, California, United States
- Children's Hospital of Orange County, Orange, California, United States
- Stanford University School of Medicine, Palo Alto, California, United States
- Rady Children's Hospital of San Diego, San Diego, California, United States
- Sharp Mary Birch Hospital for Women and Newborns, San Diego, California, United States
- Connecticut Children's Medical Center, Hartford, Connecticut, United States
- Winnie Palmer Hospital for Women and Babies, Orlando, Florida, United States
- University of So Florida College of Medicine, Tampa, Florida, United States
- Medical College of Georgia, Augusta, Georgia, United States
- Advocate Lutheran General Children's Hospital, Park Ridge, Illinois, United States
- Riley Hospital for Children, Indianapolis, Indiana, United States
- University of Louisville School of Medicine, Louisville, Kentucky, United States
- Hennepin County Medical Center, Minneapolis, Minnesota, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00931632 on ClinicalTrials.govOther trials for Bronchopulmonary dysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06373289Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm InfantsUniversity of Alabama at Birmingham
- RECRUITINGNCT07109791National Surveillance and Prevention of Neonatal VAPUniversity of Alberta
- RECRUITINGPHASE2NCT07561125Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowInternational Peace Maternity and Child Health Hospital
- RECRUITINGPHASE2NCT06915441Lipid Infusions to Optimize Nutrition TrialThe University of Texas Health Science Center, Houston
- RECRUITINGPHASE1, PHASE2NCT07101640PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary DysplasiaDuke University
- RECRUITINGNCT07273643Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and MortalityUniversity Hospital, Montpellier
- RECRUITINGEARLY PHASE1NCT07120971Metformin for Premature Infants With Bronchopulmonary DysplasiaMedical College of Wisconsin
- RECRUITINGPHASE1NCT06589245Inhaled Ciclesonide Study in Preterm InfantsVenkatesh Sampath